Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down 0.04% Nasdaq Down 0.75%
Streaming
Ticker Tape: On

Arena Pharmaceuticals, Inc. (ARNA)

-NasdaqGS
6.18 Down 0.16(2.54%) 3:48PM EDT - Nasdaq Real Time Price
Get the big picture on all your investments.
Prev Close:6.34
Open:6.31
Bid:6.14 x 7300
Ask:6.15 x 2400
1y Target Est:7.83
Beta:-2.3
Earnings Date:Apr 28 - May 2 (Est.)
Day's Range:6.11 - 6.33
52wk Range:4.05 - 9.25
Volume:4,281,464
Avg Vol (3m):5,544,230
Market Cap:1.35B
P/E (ttm):N/A
EPS (ttm):-0.09
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARNADown 2.54%1.35B
GSKDown 0.27%132.12B
OREXDown 2.63%619.04M
RHHBYUp 0.11%123.31B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):17.08
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.41
Quarterly EPS Est (Mar-14) :-0.10
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):0.12

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback